Compare SailPoint Inc. Common Stock (SAIL) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SailPoint Inc. Common Stock vs Tango Therapeutics Inc. — how do they compare? SailPoint Inc. Common Stock trades at $19 (market cap $11.03B), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.74B). The key difference: SailPoint Inc. Common Stock is far larger — about 2.9× Tango Therapeutics Inc.'s market cap, and SailPoint Inc. Common Stock is more actively traded (4,993,232 versus 3,438,781). Which is the better fit depends on your goals — on Pluang, investors hold SailPoint Inc. Common Stock for 0 Days and Tango Therapeutics Inc. for 0 Days on average.
| SAIL | TNGX | |
|---|---|---|
Market Cap | $11.03B | $3.74B |
Volume | 4,993,232 | 3,438,781 |
Sector | Technology | Health |
52-Week High | $22.85 | $32.90 |
52-Week Low | $10.49 | $7.50 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.72B | $2.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About SailPoint Inc. Common Stock
SailPoint, Inc. develops identity security software that helps enterprises manage and govern access to applications and data across users, machines, and AI agents. Its unified identity security platform combines automation and intelligence to control identity-related risk at scale for large organizations.
Read more on SAIL →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
